Doctor-Patient Trust Among Chronic Pain Patients on Chronic Opioid Therapy after Opioid Risk Reduction Initiatives: A Survey

References

1. 1.↵
   1. Kelley JM,
   2. Kraft-Todd G,
   3. Schapira L,
   4. Kossowsky J,
   5. Riess H

   . The influence of the patient-clinician relationship on healthcare outcomes: a systematic review and meta-analysis of randomized controlled trials. PLoS One 2014;9:e94207.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Lobo CP,
   2. Pfalzgraf AR,
   3. Giannetti V,
   4. Kanyongo G

   . Impact of invalidation and trust in physicians on health outcomes in fibromyalgia patients. Prim Care Companion CNS Disord. 2014;16.
3. 3.↵
   1. Dorr Goold S,
   2. Lipkin M Jr.

   . The doctor-patient relationship: challenges, opportunities, and strategies. J Gen Intern Med 1999;14:S26–33.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Pearson SD,
   2. Raeke LH

   . Patients' trust in physicians: many theories, few measures, and little data. J Gen Intern Med 2000;15:509–13.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Vowles KE,
   2. Thompson M

   . The patient-provider relationship in chronic pain. Curr Pain Headache Rep 2012;16:133–8.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Hadi MA,
   2. Alldred DP,
   3. Briggs M,
   4. Marczewski K,
   5. Closs SJ

   . ‘Treated as a number, not treated as a person’: a qualitative exploration of the perceived barriers to effective pain management of patients with chronic pain. BMJ Open 2017;7:e016454.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Upshur CC,
   2. Bacigalupe G,
   3. Luckmann R

   . “They don't want anything to do with you”: patient views of primary care management of chronic pain. Pain Med 2010;11:1791–8.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Clarke A,
   2. Martin D,
   3. Jones D,
   4. et al

   . “I try and smile, I try and be cheery, I try not to be pushy. I try to say ‘I'm here for help’ but I leave feeling … worried”: a qualitative study of perceptions of interactions with health professionals by community-based older adults with chronic pain. PLoS One 2014;9:e105450.

   OpenUrl
9. 9.↵
   1. Toye F,
   2. Seers K,
   3. Allcock N,
   4. et al

   . Patients' experiences of chronic non-malignant musculoskeletal pain: a qualitative systematic review. Br J Gen Pract 2013;63:e829–841.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Buchman DZ,
    2. Ho A,
    3. Illes J

    . You present like a drug addict: patient and clinician perspectives on trust and trustworthiness in chronic pain management. Pain Med 2016;17:1394–406.

    OpenUrl
11. 11.↵
    1. Buchman DZ,
    2. Ho A

    . What's trust got to do with it? Revisiting opioid contracts. J Med Ethics 2014;40:673–7.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Toye F,
    2. Seers K,
    3. Tierney S,
    4. Barker KL

    . A qualitative evidence synthesis to explore healthcare professionals' experience of prescribing opioids to adults with chronic non-malignant pain. BMC Fam Pract 2017;18:94.

    OpenUrl
13. 13.↵
    1. Group WSAMD

    . Interagency guideline on opioid dosing for chronic non-cancer pain: an educational aid to improve care and safety with opioid therapy. 2010 update. 2014. Published in 2014. Accessed on October 17, 2017.
14. 14.↵
    1. Johnson H,
    2. Paulozzi L,
    3. Porucznik C,
    4. Mack K,
    5. Herter B

    . Decline in drug overdose deaths after state policy changes — Florida, 2010–2012. MMWR Morb Mortal Wkly Rep. 2014;63:569–74.

    OpenUrlPubMed
15. 15.↵
    University PCoEaB. Mandating PDMP participation by medical providers: current status and experience in selected states. 2014.
16. 16.↵
    1. Dowell D,
    2. Haegerich TM,
    3. Chou R

    . CDC Guideline for prescribing opioids for chronic pain–United States, 2016. JAMA 2016;315:1624–45.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Inslee J

    . Washington State is taking action on the opioid epidemic. Available from: http://www.governor.wa.gov/sites/default/files/exe_order/OpioidEpidemic.pdf. Published 2016. Accessed October 17, 2017.
18. 18.↵
    1. Von Korff M,
    2. Walker RL,
    3. Saunders K,
    4. et al

    . Prevalence of prescription opioid use disorder among chronic opioid therapy patients after health plan opioid dose and risk reduction initiatives. Int J Drug Policy 2017;46:90–8.

    OpenUrl
19. 19.↵
    1. Strom B

    1. Saunders KW,
    2. Davis RL,
    3. Stergachis A

    . Group Health Cooperative, 4th ed. In: Strom B, editor. Pharmacoepidemiology. East Essex, England: John Wiley and Sons; 2005.
20. 20.↵
    1. Saunders KW,
    2. Shortreed S,
    3. Thielke S,
    4. et al

    . Evaluation of health plan interventions to influence chronic opioid therapy prescribing. Clin J Pain 2015;31:820–9.

    OpenUrl
21. 21.↵
    1. Krebs EE,
    2. Lorenz KA,
    3. Bair MJ,
    4. et al

    . Development and initial validation of the PEG, a three-item scale assessing pain intensity and interference. J Gen Intern Med 2009;24:733–8.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Hasin D,
    2. Samet S,
    3. Nunes E,
    4. Meydan J,
    5. Matseoane K,
    6. Waxman R

    . Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV. Am J Psychiatry 2006;163:689–96.

    OpenUrlCrossRefPubMedWeb of Science
23. 23.↵
    1. Hasin DS,
    2. Greenstein E,
    3. Aivadyan C,
    4. et al

    . The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): procedural validity of substance use disorders modules through clinical re-appraisal in a general population sample. Drug Alcohol Depend 2015;148:40–6.

    OpenUrlCrossRefPubMed
24. 24.↵
    1. Kroenke K,
    2. Strine TW,
    3. Spitzer RL,
    4. Williams JB,
    5. Berry JT,
    6. Mokdad AH

    . The PHQ-8 as a measure of current depression in the general population. J Affect Disord 2009;114:163–173.

    OpenUrlCrossRefPubMedWeb of Science
25. 25.↵
    1. Romano PS,
    2. Roos LL,
    3. Jollis JG

    . Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol 1993;46:1075–1079, discussion 1081–1090.

    OpenUrlCrossRefPubMedWeb of Science
26. 26.↵
    1. Shortreed SM,
    2. Von Korff M,
    3. Thielke S,
    4. et al

    . Electronic health records to evaluate and account for non-response bias: a survey of patients using chronic opioid therapy. Obs Stud 2016;2:24–38.

    OpenUrl
27. 27.↵
    1. Little RJ,
    2. Rubin DB

    . Statistical analysis with missing data. New York: Wiley; 2002.
28. 28.↵
    1. Horvitz DG,
    2. TD

    . A generalization of sampling without replacement from a finite universe. J Am Stat Assoc 1952;47:663–85.

    OpenUrlCrossRefWeb of Science
29. 29.↵
    1. Rotnitzky ARJ

    . Semiparametric estimation of models for means and covariances in the presence of missing data. Scand J Stat 1995;22:323–33.

    OpenUrlWeb of Science
30. 30.↵
    1. Von Korff M,
    2. Dublin S,
    3. Walker RL,
    4. et al

    . The impact of opioid risk reduction initiatives on high-dose opioid prescribing for patients on chronic opioid therapy. J Pain 2016;17:101–10.

    OpenUrl
31. 31.↵
    1. Thakral M,
    2. Walker RL,
    3. Saunders K,
    4. et al

    . Comparing pain and depressive symptoms of chronic opioid therapy patients receiving dose reduction and risk mitigation initiatives with usual care. J Pain 2018;19:111–20.

    OpenUrl
32. 32.↵
    1. Esquibel AY,
    2. Borkan J

    . Doctors and patients in pain: Conflict and collaboration in opioid prescription in primary care. Pain 2014;155:2575–82.

    OpenUrlCrossRefPubMed
33. 33.↵
    1. Blake S,
    2. Ruel B,
    3. Seamark C,
    4. Seamark D

    . Experiences of patients requiring strong opioid drugs for chronic non-cancer pain: a patient-initiated study. Br J Gen Pract 2007;57:101–8.

    OpenUrlAbstract/FREE Full Text
34. 34.↵
    1. Vallerand A,
    2. Nowak L

    . Chronic opioid therapy for nonmalignant pain: the patient's perspective. Part II–barriers to chronic opioid therapy. Pain Manag Nurs 2010;11:126–31.

    OpenUrlCrossRefPubMed
35. 35.↵
    1. Bergman AA,
    2. Matthias MS,
    3. Coffing JM,
    4. Krebs EE

    . Contrasting tensions between patients and PCPs in chronic pain management: a qualitative study. Pain Med 2013;14:1689–97.

    OpenUrlCrossRefPubMed
36. 36.↵
    1. Harle CA,
    2. Bauer SE,
    3. Hoang HQ,
    4. Cook RL,
    5. Hurley RW,
    6. Fillingim RB

    . Decision support for chronic pain care: how do primary care physicians decide when to prescribe opioids? a qualitative study. BMC Fam Pract 2015;16:48.

    OpenUrl
37. 37.↵
    1. Berg KM,
    2. Arnsten JH,
    3. Sacajiu G,
    4. Karasz A

    . Providers' experiences treating chronic pain among opioid-dependent drug users. J Gen Intern Med 2009;24:482–8.

    OpenUrlCrossRefPubMed
38. 38.↵
    1. Nicolaidis C

    . Police officer, deal-maker, or health care provider? Moving to a patient-centered framework for chronic opioid management. Pain Med 2011;12:890–7.

    OpenUrlCrossRefPubMed
39. 39.↵
    1. Jamison RN,
    2. Sheehan KA,
    3. Scanlan E,
    4. Matthews M,
    5. Ross EL

    . Beliefs and attitudes about opioid prescribing and chronic pain management: survey of primary care providers. J Opioid Manag 2014;10:375–82.

    OpenUrlCrossRefPubMed
40. 40.↵
    1. Kennedy LC,
    2. Binswanger IA,
    3. Mueller SR,
    4. et al

    . “Those conversations in my experience don't go well”: a qualitative study of primary care provider experiences tapering long-term opioid medications. Pain Med. In press.
41. 41.↵
    1. Hall MA

    . Researching medical trust in the United States. J Health Organ Manag 2006;20:456–67.

    OpenUrlPubMed
42. 42.↵
    1. Rolfe A,
    2. Cash-Gibson L,
    3. Car J,
    4. Sheikh A,
    5. McKinstry B

    . Interventions for improving patients' trust in doctors and groups of doctors. Cochrane Database Syst Rev 2014:CD004134.
43. 43.↵
    1. Anderson LA,
    2. Dedrick RF

    . Development of the Trust in Physician scale: a measure to assess interpersonal trust in patient-physician relationships. Psychol Rep 1990;67:1091–1100.

    OpenUrlCrossRefPubMedWeb of Science
44. 44.↵
    1. Safran DG,
    2. Kosinski M,
    3. Tarlov AR,
    4. et al

    . The Primary Care Assessment Survey: tests of data quality and measurement performance. Med Care 1998;36:728–39.

    OpenUrlCrossRefPubMedWeb of Science
45. 45.↵
    1. Kao AC,
    2. Green DC,
    3. Davis NA,
    4. Koplan JP,
    5. Cleary PD

    . Patients' trust in their physicians: effects of choice, continuity, and payment method. J Gen Intern Med 1998;13:681–6.

    OpenUrlCrossRefPubMedWeb of Science
46. 46.↵
    1. Kao AC,
    2. Green DC,
    3. Zaslavsky AM,
    4. Koplan JP,
    5. Cleary PD

    . The relationship between method of physician payment and patient trust. JAMA 1998;280:1708–14.

    OpenUrlCrossRefPubMedWeb of Science
47. 47.↵
    1. Thielke SM,
    2. Shortreed SM,
    3. Saunders K,
    4. Turner JA,
    5. LeResche L,
    6. Von Korff M

    . A prospective study of predictors of long-term opioid use among patients with chronic noncancer pain. Clin J Pain 2017;33:198–204.

    OpenUrl
48. 48.↵
    1. Von Korff M,
    2. Turner JA,
    3. Shortreed SM,
    4. et al

    . Timeliness of care planning upon initiation of chronic opioid therapy for chronic pain. Pain Med 2016;17:511–20.

    OpenUrl
49. 49.↵
    1. Trescott CE,
    2. Beck RM,
    3. Seelig MD,
    4. Von Korff MR

    . Group Health's initiative to avert opioid misuse and overdose among patients with chronic noncancer pain. Health Aff (Millwood) 2011;30:1420–4.

    OpenUrlAbstract/FREE Full Text
50. 50.↵
    1. Turner JA,
    2. Saunders K,
    3. Shortreed SM,
    4. et al

    . Chronic opioid therapy risk reduction initiative: impact on urine drug testing rates and results. J Gen Intern Med 2014;29:305–11.

    OpenUrlCrossRefPubMed
51. 51.↵
    1. Von Korff MSK,
    2. Dublin S,
    3. Walker RL,
    4. et al

    . Impact of risk reduction initiatives on rates of opioid overdose. J Pain. Under review.